Amanda Feilding: From Taboo to Treatment: The Coming of Age of Psychedelic Medicine

Psychedelic medicine is currently undergoing a transformative shift from social taboo to validated clinical treatment. The Beckley Foundation has played a pivotal role in this change by bridging the gap between scientific investigation and policy reform, focusing on unlocking the therapeutic potential of these compounds through rigorous neuroimaging and clinical studies. By demonstrating how substances like psilocybin and LSD alter brain connectivity and modulate the default-mode network, researchers are beginning to understand the biological mechanisms behind significant improvements in conditions like treatment-resistant depression and addiction. This progress represents the culmination of decades of advocacy to change global drug policies and reverse the restrictive legacy of historical prohibitions.